Target Healthcare REIT (LON:THRL) Stock Keeps Buy Rating at Jefferies Financial Group

Target Healthcare REIT (LON:THRL)‘s stock had its “buy” rating reiterated by equities research analysts at Jefferies Financial Group in a report issued on Thursday, Digital Look reports. They currently have a GBX 124 price objective on the stock. Jefferies Financial Group’s price target indicates a potential upside of 8.01% from the company’s previous close.

Target Healthcare REIT Trading Up 1.4%

Shares of THRL traded up GBX 1.60 during trading hours on Thursday, reaching GBX 114.80. 1,097,623 shares of the stock traded hands, compared to its average volume of 4,660,905. The stock has a fifty day simple moving average of GBX 111.87 and a 200 day simple moving average of GBX 109.06. Target Healthcare REIT has a 52 week low of GBX 92 and a 52 week high of GBX 117. The company has a market cap of £712.03 million, a price-to-earnings ratio of 8.62, a PEG ratio of 1.48 and a beta of 0.71.

Target Healthcare REIT (LON:THRL) last released its quarterly earnings results on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. Analysts predict that Target Healthcare REIT will post 6.22 earnings per share for the current fiscal year.

About Target Healthcare REIT

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.